Literature DB >> 11738850

Pathophysiology of Rett syndrome from the stand point of clinical characteristics.

M Segawa1.   

Abstract

In this report, we reviewed the characteristics of motor development and motor symptoms of Rett Syndrome (RTT) and demarcated the early and pathognomonic motor symptom which correlates to the impairment of the higher cortical function (HCF) assessed by the ability of language. It is suggested that failure of locomotion in late infancy is the primary and pathognomonic symptom. Thus, the impairment of the neurons or neuronal systems involving locomotion is suggested as the primary lesion in the pathophysiology of RTT not only for motor dysfunction but also for the failure in the development of language and cognitive function. On the other hand the neuronal systems involving the loss of purposeful hand use and the stereotyped hand movement, the most characteristic and diagnostic symptoms of RTT appearing in early childhood, are affected later or secondarily but induce further degradation of the HCF. Hypofunction of the aminergic neurons in the brainstem and midbrain is suggested as the cause of dysfunction of these neuronal systems, for those of locomotion, the noradrenarlin (NA) and/or the serotonin (5HT) neurons and for the stereotyped hand movement the dopamine (DA) neurons. The NA and/or the 5HT neurons in the brain stem may be involved primarily and may cause dysfunction of the midbrain DA neuron directly or indirectly through affecting the pedunculopontine nuclei.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738850     DOI: 10.1016/s0387-7604(01)00352-7

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

Review 1.  Neural stem cells: mechanisms and modeling.

Authors:  Jun Yao; Yangling Mu; Fred H Gage
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

Review 2.  Post-inspiratory discharges are the centrepiece of respiratory disrhythmia in a gene knockout model of Rett syndrome.

Authors:  Peter M Lalley
Journal:  J Physiol       Date:  2007-01-18       Impact factor: 5.182

3.  Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities.

Authors:  Rodney C Samaco; Caleigh Mandel-Brehm; Hsiao-Tuan Chao; Christopher S Ward; Sharyl L Fyffe-Maricich; Jun Ren; Keith Hyland; Christina Thaller; Stephen M Maricich; Peter Humphreys; John J Greer; Alan Percy; Daniel G Glaze; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

4.  Early intervention with psychostimulants or antidepressants to increase methyl-CpG-binding protein 2 (MeCP2) expressions: a potential therapy for Rett syndrome.

Authors:  Chia-Ho Pan; Shihjen Tsai
Journal:  Med Sci Monit       Date:  2012-01

5.  Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice.

Authors:  Min Jung Park; Susan Aja; Qun Li; Alicia L Degano; Judith Penati; Justin Zhuo; Charles R Roe; Gabriele V Ronnett
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

6.  Clinical characteristics of children with rett syndrome.

Authors:  Zee-A Han; Ha Ra Jeon; Seong Woo Kim; Jin Young Park; Hee Jung Chung
Journal:  Ann Rehabil Med       Date:  2012-06-30

7.  Peripheral administration of brain-derived neurotrophic factor to Rett syndrome animal model: a possible approach for the treatment of Rett syndrome.

Authors:  Shih-Jen Tsai
Journal:  Med Sci Monit       Date:  2012-08

8.  Spectrum of MECP2 mutations in Vietnamese patients with RETT syndrome.

Authors:  Huong Le Thi Thanh; Trinh Do Thi Diem; Chinh Vu Duy; Ha Ly Thi Thanh; Hoa Bui Thi Phuong; Liem Nguyen Thanh
Journal:  BMC Med Genet       Date:  2018-08-06       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.